Treatment of metastatic adrenal cortical carcinoma with cisplatin and etoposide (VP‐16)

D. H. Johnson, F. A. Greco

Research output: Contribution to journalArticle

46 Scopus citations

Abstract

Two patients with metastatic adrenal cortical carcinoma were treated with cisplatin and etoposide. Both achieved a partial remission after only one cycle. One patient had a „nonfunctioning” tumor that had previously regressed on mitotane whereas the second patient presented with classical Cushing's syndrome. Although the latter patient's urinary 17‐ketosteroids normalized while receiving mitotane, the tumor itself failed to regress objectively. Cisplatin plus etoposide appears to be an active combination for the treatment of metastatic adrenal cortical carcinoma.

Original languageEnglish (US)
Pages (from-to)2198-2202
Number of pages5
JournalCancer
Volume58
Issue number10
DOIs
StatePublished - Nov 15 1986

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Treatment of metastatic adrenal cortical carcinoma with cisplatin and etoposide (VP‐16)'. Together they form a unique fingerprint.

  • Cite this